{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:43:03Z","timestamp":1776930183219,"version":"3.51.2"},"reference-count":5,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.parkreldis.2010.07.012","type":"journal-article","created":{"date-parts":[[2010,8,18]],"date-time":"2010-08-18T06:54:14Z","timestamp":1282114454000},"page":"688-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Acute homocysteine rise after repeated levodopa application in patients with Parkinson\u2019s disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Thomas","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Muhlack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.parkreldis.2010.07.012_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1586\/14737175.8.6.957","article-title":"Role of homocysteine in the treatment of Parkinson\u2019s disease","volume":"8","author":"M\u00fcller","year":"2008","journal-title":"Exp Rev Neurother"},{"issue":"9","key":"10.1016\/j.parkreldis.2010.07.012_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/mds.22607","article-title":"Homocysteine levels after acute levodopa intake in patients with Parkinson\u2019s disease","volume":"24","author":"M\u00fcller","year":"2009","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.parkreldis.2010.07.012_bib3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00702-004-0262-4","article-title":"The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats","volume":"112","author":"Nissinen","year":"2005","journal-title":"J Neural Transm"},{"issue":"12","key":"10.1016\/j.parkreldis.2010.07.012_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/mds.20253","article-title":"Modest increase in plasma homocysteine follows levodopa initiation in Parkinson\u2019s disease","volume":"19","author":"O\u2019Suilleabhain","year":"2004","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.parkreldis.2010.07.012_bib5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/mds.22482","article-title":"Cysteine elevation in levodopa-treated patients with Parkinson\u2019s disease","volume":"24","author":"M\u00fcller","year":"2009","journal-title":"Mov Disord"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201000177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201000177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:12:10Z","timestamp":1761178330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380201000177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S135380201000177X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2010.07.012","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute homocysteine rise after repeated levodopa application in patients with Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2010.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}